Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.28−0.22 (-2.37%)
Close on Nov 17, 2026Market cap $596.89MP/E –Yield –
Cullinan Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cullinan Therapeutics's market cap was $730.32M on Nov 11, 2026, against $671.70M a year earlier. Over the last 5 years it ranged from $350.21M to $1.42B, with a median of $603.36M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $730.32M | +19.4% |
| 2025 | Dec 31, 2025 | $611.44M | -13.7% |
| 2024 | Dec 31, 2024 | $708.16M | +62.5% |
| 2023 | Dec 29, 2023 | $435.73M | -9.7% |
| 2022 | Dec 30, 2022 | $482.59M | -28.4% |
| 2021 | Dec 31, 2021 | $673.69M | – |
See a number that looks wrong?